1.Investigating the prevalence and clinical symptoms of non-convulsive seizures in emergency department patients with unexplained altered consciousness using real-time portable continuous electroencephalographic monitoring
Soo Wook KIM ; Won Soek YANG ; Jin Hyouk KIM ; Sang Ook HA ; Young Sun PARK
Journal of the Korean Society of Emergency Medicine 2024;35(5):353-363
		                        		
		                        			 Objective:
		                        			A wireless electroencephalography (EEG) headset was applied to patients with an unclear etiology of an altered mental status suspected of non-convulsive seizures in the emergency department. 
		                        		
		                        			Methods:
		                        			The study included patients who presented to the emergency department with an altered mental status from January 1, 2020, to April 30, 2023. The patients with abnormal findings in brain imaging or those with typical seizure movement were excluded. Real-time portable continuous EEG monitoring was conducted on patients with persistent altered consciousness despite receiving conservative treatments and showing improvement in vital signs and blood tests within 3 hours. The baseline characteristics, degree of consciousness alteration and neurological symptoms, initial clinical diagnosis, EEG findings, and medications used in cases where epileptiform discharges were examined. The clinical outcomes were analyzed retrospectively. 
		                        		
		                        			Results:
		                        			Among 26 patients, six patients showed epileptiform discharges. The final diagnoses included uremic encephalopathy (n=2), septic encephalopathy due to pneumonia (n=1), urinary tract infection (n=1), diabetic ketoacidosis (n=1), and mental change only (n=1). The associated symptoms were myoclonus in three patients and abnormal eye movements in two patients. 
		                        		
		                        			Conclusion
		                        			In cases where the causes of altered mental status remain unexplained despite appropriate evaluations and treatments, particularly when accompanied by myoclonus or abnormal eye movements, it is crucial to consider the possibility of non-convulsive seizures and promptly perform an EEG to differentiate and diagnose the underlying condition, even if initial tests and treatments have been performed. 
		                        		
		                        		
		                        		
		                        	
2.Comparison of Factors Associated With Direct Versus Transferred-in Admission to Government-Designated Regional Centers Between Acute Ischemic Stroke and Myocardial Infarction in Korea
Dae-Hyun KIM ; Seok-Joo MOON ; Juneyoung LEE ; Jae-Kwan CHA ; Moo Hyun KIM ; Jong-Sung PARK ; Byeolnim BAN ; Jihoon KANG ; Beom Joon KIM ; Won-Seok KIM ; Chang-Hwan YOON ; Heeyoung LEE ; Seongheon KIM ; Eun Kyoung KANG ; Ae-Young HER ; Cindy W YOON ; Joung-Ho RHA ; Seong-Ill WOO ; Won Kyung LEE ; Han-Young JUNG ; Jang Hoon LEE ; Hun Sik PARK ; Yang-Ha HWANG ; Keonyeop KIM ; Rock Bum KIM ; Nack-Cheon CHOI ; Jinyong HWANG ; Hyun-Woong PARK ; Ki Soo PARK ; SangHak YI ; Jae Young CHO ; Nam-Ho KIM ; Kang-Ho CHOI ; Juhan KIM ; Jae-Young HAN ; Jay Chol CHOI ; Song-Yi KIM ; Joon-Hyouk CHOI ; Jei KIM ; Min Kyun SOHN ; Si Wan CHOI ; Dong-Ick SHIN ; Sang Yeub LEE ; Jang-Whan BAE ; Kun Sei LEE ; Hee-Joon BAE
Journal of Korean Medical Science 2022;37(42):e305-
		                        		
		                        			 Background:
		                        			There has been no comparison of the determinants of admission route between acute ischemic stroke (AIS) and acute myocardial infarction (AMI). We examined whether factors associated with direct versus transferred-in admission to regional cardiocerebrovascular centers (RCVCs) differed between AIS and AMI. 
		                        		
		                        			Methods:
		                        			Using a nationwide RCVC registry, we identified consecutive patients presenting with AMI and AIS between July 2016 and December 2018. We explored factors associated with direct admission to RCVCs in patients with AIS and AMI and examined whether those associations differed between AIS and AMI, including interaction terms between each factor and disease type in multivariable models. To explore the influence of emergency medical service (EMS) paramedics on hospital selection, stratified analyses according to use of EMS were also performed. 
		                        		
		                        			Results:
		                        			Among the 17,897 and 8,927 AIS and AMI patients, 66.6% and 48.2% were directly admitted to RCVCs, respectively. Multivariable analysis showed that previous coronary heart disease, prehospital awareness, higher education level, and EMS use increased the odds of direct admission to RCVCs, but the odds ratio (OR) was different between AIS and AMI (for the first 3 factors, AMI > AIS; for EMS use, AMI < AIS). EMS use was the single most important factor for both AIS and AMI (OR, 4.72 vs. 3.90). Hypertension and hyperlipidemia increased, while living alone decreased the odds of direct admission only in AMI;additionally, age (65–74 years), previous stroke, and presentation during non-working hours increased the odds only in AIS. EMS use weakened the associations between direct admission and most factors in both AIS and AMI. 
		                        		
		                        			Conclusions
		                        			Various patient factors were differentially associated with direct admission to RCVCs between AIS and AMI. Public education for symptom awareness and use of EMS is essential in optimizing the transportation and hospitalization of patients with AMI and AIS. 
		                        		
		                        		
		                        		
		                        	
3.Effect of coronavirus disease 2019 pandemic on children’s visits to the emergency department
Hong Min KIM ; Sang Ook HA ; Won Seok YANG ; Young Sun PARK ; Jin Hyouk KIM
Pediatric Emergency Medicine Journal 2022;9(1):10-16
		                        		
		                        			 Purpose:
		                        			In the coronavirus disease 2019 pandemic, it is essential to supplement the changes in visiting patterns of individual emergency departments (EDs) to determine how to allocate emergency medicine resources. We compared the clinical features of children visiting the ED before and during the pandemic. 
		                        		
		                        			Methods:
		                        			Children younger than 18 years who visited the ED from February 2019 through December 2020, except January 2020, were enrolled, and divided into those who visited before and after January 2020 (the pre-pandemic and pandemic groups, respectively). We compared the 2 groups in terms of the baseline characteristics (age, sex, mode and route of arrival, cause of visit, and time of visit), chief complaint, ED diagnosis, initial acuity and its accuracy, and ED outcomes (length of stay and disposition). 
		                        		
		                        			Results:
		                        			The 31,036 children were categorized into the pre-pandemic (21,027 [67.8%]) and pandemic (10,009 [32.2%]) groups with a 52.4% decrease in the number of visits to the ED in the latter group. This decrease was more prominent in age 2-5 years (from 37.3% to 33.2%; P < 0.001), fever as a chief complaint (from 27.8% to 16.5%), diagnoses related to infection or the respiratory system (from 36.8% to 14.3%) or transfer to the ED (from 8.1% to 6.4%; P < 0.001). In contrast, increases were noted in age 12-17 years (from 14.9% to 17.4%; P < 0.001), injury (from 36.5% to 52.5%; P < 0.001), visits in the evening (from 54.9% to 57.4%; P < 0.001), length of stay longer than 6 hours (from 3.5% to 6.3%; P = 0.033), and low acuity (from 97.8% to 98.2%; P = 0.031). 
		                        		
		                        			Conclusion
		                        			The pandemic has brought about changes in visiting patterns of the ED. This study may help prepare strategies for the appropriate allocation and deployment of emergency medicine resources in the pandemic era. 
		                        		
		                        		
		                        		
		                        	
4.Characteristics of Adult Severe Refractory Asthma in Korea Analyzed From the Severe Asthma Registry.
Min Hye KIM ; Sang Heon KIM ; So Young PARK ; Ga Young BAN ; Joo Hee KIM ; Jae Woo JUNG ; Ji Yong MOON ; Woo Jung SONG ; Hyouk Soo KWON ; Jae Woo KWON ; Jae Hyun LEE ; Hye Ryun KANG ; Jong Sook PARK ; Tae Bum KIM ; Heung Woo PARK ; Kwang Ha YOO ; Yeon Mok OH ; Young Il KOH ; An Soo JANG ; Byung Jae LEE ; Young Joo CHO ; Sang Heon CHO ; Hae Sim PARK ; Choon Sik PARK ; Ho Joo YOON ; You Sook CHO
Allergy, Asthma & Immunology Research 2019;11(1):43-54
		                        		
		                        			
		                        			PURPOSE: Although mild to moderate asthma is much more common, the morbidity and mortality of severe asthma are much higher. This study was performed to identify and analyze the clinical characteristics of severe asthma in Korea. METHODS: We registered patients with severe refractory asthma into the Severe Asthma Registry supported by the Severe Asthma Work Group of the Korean Academy of Asthma, Allergy and Clinical Immunology. Patients were enrolled since 2010 from the 15 university hospitals nationwide in Korea. Severe asthma was defined according to modified European Respiratory Society/American Thoracic Society criteria. Information on demographics, medical history, pulmonary function tests and skin prick tests was collected; the clinical characteristics of severe asthmatics were analyzed from the collected data. RESULTS: A total of 489 patients were enrolled with a mean age of 62.3; 45% are male. Sixty percent of patients received Global Initiative for Asthma step 4 treatment, and 30% received step 5 treatment. The most common comorbidities were allergic rhinitis (58.7%). Aspirin hypersensitivity was observed in 14.0%. Approximately half (53.9%) are non-smokers. Atopy was proven in 38.5% of the patients. Regarding asthma medications, inhaled corticosteroids and long-acting β-agonist combination inhalers were most commonly prescribed (96.5%), followed by leukotriene antagonists (71.0%). A recombinant anti-immunoglobulin E monoclonal antibody (omalizumab) has been used in 1.8% of the patients. The mean forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1) and FEV1/FVC were 78.7%, 67.5% and 67.9% of predicted values, respectively. The mean Asthma Control Test and quality of life questionnaire scores were 16.5 out of 25 and 59.5 out of 85, respectively. CONCLUSIONS: The baseline characteristics of severe asthma patients in the Korea Severe Asthma Registry were analyzed and reported for the first time. With this cohort, further prospective studies should be performed to search for ways to improve management of severe refractory asthma.
		                        		
		                        		
		                        		
		                        			Adrenal Cortex Hormones
		                        			;
		                        		
		                        			Adult*
		                        			;
		                        		
		                        			Allergy and Immunology
		                        			;
		                        		
		                        			Aspirin
		                        			;
		                        		
		                        			Asthma*
		                        			;
		                        		
		                        			Cohort Studies
		                        			;
		                        		
		                        			Comorbidity
		                        			;
		                        		
		                        			Demography
		                        			;
		                        		
		                        			Forced Expiratory Volume
		                        			;
		                        		
		                        			Hospitals, University
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity
		                        			;
		                        		
		                        			Korea*
		                        			;
		                        		
		                        			Leukotriene Antagonists
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Nebulizers and Vaporizers
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Respiratory Function Tests
		                        			;
		                        		
		                        			Rhinitis, Allergic
		                        			;
		                        		
		                        			Skin
		                        			;
		                        		
		                        			Vital Capacity
		                        			
		                        		
		                        	
5.Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey.
Sang Heon KIM ; Ji Yong MOON ; Jae Hyun LEE ; Ga Young BAN ; Sujeong KIM ; Mi Ae KIM ; Joo Hee KIM ; Min Hye KIM ; Chan Sun PARK ; So Young PARK ; Hyouk Soo KWON ; Jae Woo KWON ; Jae Woo JUNG ; Hye Ryun KANG ; Jong Sook PARK ; Tae Bum KIM ; Heung Woo PARK ; You Sook CHO ; Kwang Ha YOO ; Yeon Mok OH ; Byung Jae LEE ; An Soo JANG ; Sang Heon CHO ; Hae Sim PARK ; Choon Sik PARK ; Ho Joo YOON
Allergy, Asthma & Immunology Research 2018;10(3):225-235
		                        		
		                        			
		                        			PURPOSE: Severe asthma and asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) are difficult to control and are often associated with poor clinical outcomes. However, much is not understood regarding the diagnosis and treatment of severe asthma and ACOS. To evaluate the current perceptions of severe asthma and COPD among asthma and COPD specialists, we designed an e-mail and internet-based questionnaire survey. METHODS: Subjects were selected based on clinical specialty from among the members of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Academy of Tuberculosis and Respiratory Diseases. Of 432 subjects who received an e-mail invitation to the survey, 95 subjects, including 58 allergists and 37 pulmonologists, responded and submitted their answers online. RESULTS: The specialists estimated that the percentage of severe cases among total asthma patients in their practice was 13.9%±11.0%. Asthma aggravation by stepping down treatment was the most common subtype, followed by frequent exacerbation, uncontrolled asthma despite higher treatment steps, and serious exacerbation. ACOS was estimated to account for 20.7% of asthma, 38.0% of severe asthma, and 30.1% of COPD cases. A history of smoking, persistently low forced expiratory volume in 1 second (FEV1), and low FEV1 variation were most frequently classified as the major criteria for the diagnosis of ACOS among asthma patients. Among COPD patients, the highly selected major criteria for ACOS were high FEV1 variation, positive bronchodilator response, a personal history of allergies and positive airway hyperresponsiveness. Allergists and pulmonologists showed different assessments and opinions on asthma phenotyping, percentage, and diagnostic criteria for ACOS. CONCLUSIONS: Specialists had diverse perceptions and clinical practices regarding severe asthma and ACOS patients. This heterogeneity must be considered in future studies and strategy development for severe asthma and ACOS.
		                        		
		                        		
		                        		
		                        			Allergy and Immunology
		                        			;
		                        		
		                        			Asthma*
		                        			;
		                        		
		                        			Diagnosis
		                        			;
		                        		
		                        			Electronic Mail
		                        			;
		                        		
		                        			Forced Expiratory Volume
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity
		                        			;
		                        		
		                        			Lung Diseases, Obstructive
		                        			;
		                        		
		                        			Population Characteristics
		                        			;
		                        		
		                        			Pulmonary Disease, Chronic Obstructive
		                        			;
		                        		
		                        			Smoke
		                        			;
		                        		
		                        			Smoking
		                        			;
		                        		
		                        			Specialization*
		                        			;
		                        		
		                        			Tuberculosis
		                        			
		                        		
		                        	
6.Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database.
Soo Youn BAE ; Ku Sang KIM ; Jeong Soo KIM ; Sae Byul LEE ; Byeong Woo PARK ; Seok Won LEE ; Hyouk Jin LEE ; Hong Kyu KIM ; Ji Young YOU ; Seung Pil JUNG
Journal of Breast Cancer 2018;21(4):425-432
		                        		
		                        			
		                        			PURPOSE: Pregnancy-associated breast cancer (PABC) is rare, and its cause and prognosis are not well known. Additionally, treatment is limited with respect to the risk to the fetus. The purpose of this study was to investigate the characteristics and treatment trends of PABC and the survival rate according to the treatment. METHODS: In the Korean Breast Cancer Society Registry database, women younger than 50 years and who were diagnosed with breast cancer from 1996 to 2015 were included. PABC was defined as breast cancer diagnosed during pregnancy or within 1 year after delivery. RESULTS: We examined 411 patients with PABC and 83,381 patients with non-PABC. Over time, the proportions of patients undergoing breast-conserving surgery and sentinel lymph node biopsy increased, and neoadjuvant chemotherapy and radiation therapy administration rates also increased. In the past, the overall survival of patients with PABC was poorer than that of patients with non-PABC, but there was no difference in overall survival rates in more recent years. There was no difference in overall survival rates between patients who received neoadjuvant chemotherapy (hazard ratio [HR], 1.28; 95% confidence interval [CI], 0.66–2.49; p=0.459), but PABC conferred poorer prognosis than non-PABC in patients receiving adjuvant chemotherapy (HR, 1.63; 95% CI, 1.27–2.08; p < 0.001). CONCLUSION: There was no difference in the prognosis between patients with PABC and those with non-PABC receiving neoadjuvant chemotherapy. The increase in neoadjuvant chemotherapy according to current treatment guidelines is expected to improve the survival rate of patients with PABC.
		                        		
		                        		
		                        		
		                        			Breast Neoplasms*
		                        			;
		                        		
		                        			Breast*
		                        			;
		                        		
		                        			Chemotherapy, Adjuvant
		                        			;
		                        		
		                        			Drug Therapy*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fetus
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mastectomy, Segmental
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Prognosis*
		                        			;
		                        		
		                        			Sentinel Lymph Node Biopsy
		                        			;
		                        		
		                        			Survival Rate
		                        			
		                        		
		                        	
7.Design of Korean Noninvasive Risk Evaluation Study for Sudden Cardiac Death from Infarction or Heart Failure: Myocardial infarction study of K-REDEFINE registry.
Seung Jung PARK ; Gyo Seung HWANG ; Gi Byoung NAM ; Hyung Wook PARK ; Joong Wha CHUNG ; Seung Yong SHIN ; Sang Min KIM ; Jun Hyung KIM ; Young Soo LEE ; Yae Min PARK ; Jong Youn KIM ; Dae Hyeok KIM ; Dae Kyeong KIM ; June NAMGUNG ; Dae Hee SHIN ; Joon Hyouk CHOI ; Hyoung Seob PARK ; Jong Il CHOI ; Jin Seok KIM ; Tae Joon CHA ; Sang Weon PARK ; Jae Sun UHM ; Nam Ho KIM ; Minsoo AHN ; Dong Gu SHIN ; Nuri JANG ; Meemo PARK ; June Soo KIM
International Journal of Arrhythmia 2017;18(1):6-15
		                        		
		                        			
		                        			BACKGROUND AND OBJECTIVES: Despite significant advances in the treatment of acute myocardial infarction (MI), the prevention of sudden cardiac death (SCD), the most common mode of death in patients with MI, remains challenging. Furthermore, previous Korean MI registries did not address the issue of post-MI SCD. Additional risk stratifiers of post-MI SCD are still required to compensate for the limitation of using left ventricular ejection fraction to predict lethal arrhythmic events. SUBJECTS AND METHODS: We designed the first Korean prospective nationwide multicenter registry primarily focused on SCD; the Korean noninvasive Risk Evaluation study for sudden cardiac DEath From INfarction or heart failurE (K-REDEFINE). The registry consists of 2 groups of patients presenting with (1) acute MI or (2) acute heart failure (HF) at 25 tertiary referral cardiovascular centers. The primary endpoint of the MI group study of K-REDEFINE registry is the incidence and risk factors of post-MI SCD. In particular, the association between the risk of SCD and non-invasive Holter-based electrocardiogram (ECG) variables will be evaluated, such as T-wave alternans (marker of repolarization heterogeneity) and heart rate turbulence/variability (a marker of autonomic function). Other secondary study outcomes include atrioventricular arrhythmias, HF-related admission, repeated myocardial ischemic events, stroke, and overall deaths. CONCLUSION AND PERSPECTIVE: The K-REDEFINE registry will provide new prospects for the better management of MI patients with high risk of SCD by clarifying the burden and predictors of SCD and the clinical utility of various non-invasive ambulatory ECG-based variables in risk stratification for SCD in this patient population.
		                        		
		                        		
		                        		
		                        			Arrhythmias, Cardiac
		                        			;
		                        		
		                        			Death, Sudden, Cardiac*
		                        			;
		                        		
		                        			Electrocardiography
		                        			;
		                        		
		                        			Heart Failure*
		                        			;
		                        		
		                        			Heart Rate
		                        			;
		                        		
		                        			Heart*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Infarction*
		                        			;
		                        		
		                        			Myocardial Infarction*
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Referral and Consultation
		                        			;
		                        		
		                        			Registries
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Stroke
		                        			;
		                        		
		                        			Stroke Volume
		                        			
		                        		
		                        	
8.KAAACI Standardization Committee Report on the procedures and applications of the diagnostic tests for drug allergy.
Min Suk YANG ; Ga Young BAN ; Min Hye KIM ; Kyung Hwan LIM ; Hyouk Soo KWON ; Woo Jung SONG ; Jae Woo JUNG ; Jeongmin LEE ; Dong In SUH ; Jae Woo KWON ; Sae Hoon KIM ; Yoo Seob SHIN ; Hye Ryun KANG ; Tae Bum KIM ; Byung Jae LEE ; Ai Young LEE ; Hae Sim PARK ; Sang Heon CHO
Allergy, Asthma & Respiratory Disease 2017;5(5):239-247
		                        		
		                        			
		                        			Diagnostic methods for drug allergy include the patient's history, in vivo skin test, in vitro laboratory test, and provocation test. However, the history is often not reliable, procedures for in vivo and in vitro tests are not standardized, and provocation tests are sometimes harmful to patients. Generally, skin prick and intradermal tests are useful for immediate reactions; in contrast, patch test and delayed reading of both skin prick and intradermal tests are helpful for delayed reactions. A drug provocation test is the gold standard for both responses, and it is necessary to be aware of exact indications and contraindications with appropriate drugs, doses, and intervals. To date, several methods have been developed to detect culprit agents for drug hypersensitivity reactions, but they are neither completely well validated nor standardized. Based on this awareness and necessity, the Korean Academy of Asthma, Allergy and Clinical Immunology launched the Standardization Committee to review the international guidelines and the literature, and then developed the consensus report on the procedures and applications of diagnostic tests for drug allergy.
		                        		
		                        		
		                        		
		                        			Allergy and Immunology
		                        			;
		                        		
		                        			Asthma
		                        			;
		                        		
		                        			Consensus
		                        			;
		                        		
		                        			Diagnostic Tests, Routine*
		                        			;
		                        		
		                        			Drug Hypersensitivity*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hypersensitivity
		                        			;
		                        		
		                        			In Vitro Techniques
		                        			;
		                        		
		                        			Intradermal Tests
		                        			;
		                        		
		                        			Patch Tests
		                        			;
		                        		
		                        			Skin
		                        			;
		                        		
		                        			Skin Tests
		                        			
		                        		
		                        	
9.Design of Korean Noninvasive Risk Evaluation Study for Sudden Cardiac Death from Infarction or Heart Failure: Heart failure study of K-REDEFINE registry.
Seung Jung PARK ; Gyo Seung HWANG ; Gi Byoung NAM ; Hyung Wook PARK ; Joong Wha CHUNG ; Seung Yong SHIN ; Sang Min KIM ; Jun Hyung KIM ; Young Soo LEE ; Yae Min PARK ; Jong Youn KIM ; Dae Hyeok KIM ; Dae kyeong KIM ; June NAMGUNG ; Dae Hee SHIN ; Joon Hyouk CHOI ; Hyoung Seob PARK ; Jong Il CHOI ; Jin Seok KIM ; Tae Joon CHA ; Sang Weon PARK ; Jae Sun UHM ; Nam Ho KIM ; Minsoo AHN ; Dong Gu SHIN ; Nuri JANG ; Meemo PARK ; June Soo KIM
International Journal of Arrhythmia 2016;17(4):181-189
		                        		
		                        			
		                        			BACKGROUND AND OBJECTIVES: Sudden cardiac death (SCD) is one of the most common causes of death in patients with heart failure (HF). However, there are no available data on SCD in previous Korean HF registries. Additionally, although widely used, the utility of left ventricular (LV) ejection fraction (EF) in risk stratification for SCD is limited. SUBJECTS AND METHODS: The Korean non-invasive Risk Evaluation study for sudden cardiac DEath From INfarction or heart failurE (KREDEFINE) is the first Korean prospective, nationwide multicenter registry, primarily focused on SCD. The registry consists of 2 groups of patients presenting with (1) acute HF or (2) acute myocardial infarction (MI) at 25 tertiary referral cardiovascular centers. Using the HF-group data of the K-REDEFINE registry, the incidence and risk factors of SCD in patients with HF will be assessed. In particular, the efficacy of Holter-based ECG variables, such as T-wave alternans (marker of repolarization heterogeneity) and heart rate turbulence/ variability (maker of autonomic function), in risk stratification for SCD will be evaluated. Other cardiovascular outcomes will also be analyzed, including atrioventricular arrhythmias, HF-related admission, stroke, and overall deaths. CONCLUSION AND PERSPECTIVE: The K-REDEFINE registry will pave the way for better management of patients with HF at high risk of SCD by elucidating the burden and risk factors of SCD and the clinical utility of various non-invasive ambulatory ECG-based parameters in risk stratification for SCD in this patient population.
		                        		
		                        		
		                        		
		                        			Arrhythmias, Cardiac
		                        			;
		                        		
		                        			Cause of Death
		                        			;
		                        		
		                        			Death, Sudden, Cardiac*
		                        			;
		                        		
		                        			Electrocardiography
		                        			;
		                        		
		                        			Heart Failure*
		                        			;
		                        		
		                        			Heart Rate
		                        			;
		                        		
		                        			Heart*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Infarction*
		                        			;
		                        		
		                        			Myocardial Infarction
		                        			;
		                        		
		                        			Prospective Studies
		                        			;
		                        		
		                        			Referral and Consultation
		                        			;
		                        		
		                        			Registries
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Stroke
		                        			
		                        		
		                        	
10.Acute Ocular Manifestations after an Accidental Hydrofluoric Acid Release.
Yong Joon KIM ; Sang Hyouk PARK ; Kyung Seek CHOI
Journal of the Korean Ophthalmological Society 2013;54(11):1663-1668
		                        		
		                        			
		                        			PURPOSE: To report the ocular health of a community after an accidental release of hydrofluoric acid (HF). METHODS: The hospital records of 327 patients that were exposed to HF between Sep 9, 2012 and Oct 31, 2012 were reviewed. Demographic characteristics, subjective ocular symptoms, and the ophthalmologic examination results of the patients were analyzed retrospectively. RESULTS: Among the 327 patients, 203 patients (62.1%) were exposed to hydrofluoric acid (HF) within 1,000 m of the site of the accident. A total of 131 patients (40.1%) were exposed to HF over 3 days. The most frequently reported ocular symptoms after HF exposure were ocular pain (49.5%) and conjunctival hyperemia (37.9%). Conjunctival hyperemia (43.4%), corneal erosion (23.9%), conjunctiva papilla, and follicles (24.2% and 14.4%, respectively) were noted during ophthalmologic examinations, but 46.2% of patients were normal on examination. None of the patients had vision-threatening damages. CONCLUSIONS: In this study, severe ocular surface changes, which can affect vision, were not identified. This result could be explained by the low atmospheric HF concentration after the accident.
		                        		
		                        		
		                        		
		                        			Burns, Chemical
		                        			;
		                        		
		                        			Conjunctiva
		                        			;
		                        		
		                        			Hospital Records
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Hydrofluoric Acid*
		                        			;
		                        		
		                        			Hyperemia
		                        			;
		                        		
		                        			Vision, Ocular
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail